You are here

Electrophysiology & Arrhythmia

 

Between 1999 and 2013, the adjusted rates of hospitalization for atrial fibrillation increased nearly 1 percent year per year among Medicare fee-for-service beneficiaries, while the median Medicare inpatient expenditure per beneficiary increased from $2,932 to $4,719 per stay.

Women who were healthy at baseline had an increased risk of atrial fibrillation if they had multiple pregnancies, according to an analysis of a large cohort.

Black people with atrial fibrillation (AF) experience vastly higher rates of serious coronary events, so it’s not surprising that a growing number of clinical studies are aggressively tackling the complex issues around the impact of race—as well as gender—on management and outcomes of the heart rhythm disorder.

Nearly 80 percent of older adults who received an implantable cardioverter-defibrillator (ICD) survived at least two years, according to a registry analysis of Medicare beneficiaries.

After adjusting for multiple variables, adults who abused alcohol had increased risks of atrial fibrillation, MI and congestive heart failure, according to a longitudinal analysis. The relative risk for those outcomes were highest in adults who had no established cardiovascular risk factors.

 

Recent Headlines

Medtronic receives CE Mark for CRT pacemakers

Medtronic announced Feb. 24 that the company had received CE marks for quadripolar cardiac resynchronization therapy (CRT) pacemakers that allow patients to receive MRIs.

Patients with standard pacemakers, ICDs may safely undergo MRIs

Patients with a non-MRI conditional pacemaker or implantable cardioverter defibrillator (ICD) who received a nonthoracic MRI had no occurrences of death, lead failures, losses of capture or ventricular arrhythmias, according to a prospective registry analysis.

FDA approves catheter to treat patients with an abnormal heart rhythm

The FDA approved the Freezor Xtra cryoablation catheter to treat patients with an abnormal heart rhythm known as atrioventricular nodal re-entrant tachycardia (AVRT).

St. David’s Medical Center first to use new cardiac mapping system to treat heart arrhythmias

The Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center in Austin, Texas, is the first facility in the nation to use a new platform designed to treat heart rhythms and arrhythmias.

Atrial fibrillation hospitalizations increase, but mortality rates, readmissions decline

Between 1999 and 2013, the adjusted rates of hospitalization for atrial fibrillation increased nearly 1 percent year per year among Medicare fee-for-service beneficiaries, while the median Medicare inpatient expenditure per beneficiary increased from $2,932 to $4,719 per stay.

Multiple pregnancies may increase risk of atrial fibrillation

Women who were healthy at baseline had an increased risk of atrial fibrillation if they had multiple pregnancies, according to an analysis of a large cohort.

FDA approves MR-conditioning labeling for Abbott’s pacemaker

The FDA approved a magnetic resonance (MR)-conditioning labeling for Abbott’s Assurity MRI pacemaker and its Tendreil MRI pacing lead.

FDA grants 510(k) clearance for CardioInsight 3D mapping system

The FDA granted a 510(k) clearance for the CardioInsight noninvasive 3D mapping system, which provides 3D maps of the heart and is used to map irregular heart rhythms.

Medtronic seeks CMS approval for Micra leadless pacemaker

Medtronic plans on seeking coverage from CMS for the company’s Micra Transcatheter Pacing System, the first and only FDA-approved leadless pacemaker.

Mining the Gap: Researchers Dig for Data to Reduce Disparities in Atrial Fibrillation Treatment

Black people with atrial fibrillation (AF) experience vastly higher rates of serious coronary events, so it’s not surprising that a growing number of clinical studies are aggressively tackling the complex issues around the impact of race—as well as gender—on management and outcomes of the heart rhythm disorder.

Pages